Fig. 8From: Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibitionGraphical model describing the mechanism by which valproic acid/simvastatin combination by inhibiting the mevalonate pathway/YAP axis, specifically targets cancer stem cells, thus potentiating docetaxel antitumor effectBack to article page